Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.50 CNY | -0.51% |
|
-0.79% | -6.84% |
| Apr. 30 | Singapore Shares Surge More Than 1% as DBS Books Record Total Income | MT |
| Apr. 30 | Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5% | MT |
| Capitalization | 28.63B 4.21B 3.61B 3.31B 3.14B 5.78B 405B 5.88B 39.57B 15.33B 192B 15.78B 15.45B 668B | P/E ratio 2026 * |
29.1x | P/E ratio 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise value | 28.63B 4.21B 3.61B 3.31B 3.14B 5.78B 405B 5.88B 39.57B 15.33B 192B 15.78B 15.45B 668B | EV / Sales 2026 * |
5.35x | EV / Sales 2027 * | 4.94x |
| Free-Float |
29.13% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.51% | ||
| 1 week | -0.79% | ||
| Current month | +4.68% | ||
| 1 month | +4.42% | ||
| 3 months | -1.60% | ||
| 6 months | -9.17% | ||
| Current year | -6.84% |
| 1 week | 42.07 |  | 44.24 |
| 1 month | 38.92 | | 44.24 |
| Current year | 38.92 | | 48.2 |
| 1 year | 31.45 | | 50.97 |
| 3 years | 23.4 | | 56.26 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Ma
DFI | Director of Finance/CFO | 48 | 2023-07-20 |
Hong Zhou
CTO | Chief Tech/Sci/R&D Officer | 56 | 2017-10-09 |
Jian Wang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lei Wang
CHM | Chairman | 55 | 2024-11-25 |
Hong Zhou
BRD | Director/Board Member | 56 | 2012-11-30 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 2021-12-09 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -0.79% | +36.66% | -11.48% | 4.21B | |
| -0.08% | -3.34% | -10.35% | -10.94% | 13.33B | |
| -3.66% | -5.84% | -30.18% | -54.96% | 5.3B | |
| -2.91% | -5.83% | -10.65% | +4.12% | 4.79B | |
| -1.09% | -7.84% | +7.42% | -43.33% | 4.01B | |
| -2.05% | -3.65% | +3.05% | -9.87% | 3.75B | |
| -1.84% | -4.20% | -11.02% | -2.51% | 3.15B | |
| -1.45% | -6.76% | -3.11% | -26.34% | 2.41B | |
| -1.48% | -4.14% | -13.89% | -4.35% | 1.83B | |
| -1.31% | -0.27% | -8.22% | +34.55% | 1.8B | |
| Average | -1.64% | -3.65% | -4.03% | -12.51% | 4.46B | |
| Weighted average by Cap. | -1.41% | -3.47% | -5.29% | -15.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.35B 786M 675M 618M 586M 1.08B 75.68B 1.1B 7.39B 2.86B 35.81B 2.95B 2.89B 125B | 5.8B 852M 732M 669M 636M 1.17B 82.03B 1.19B 8.01B 3.11B 38.81B 3.2B 3.13B 135B |
| Net income | 1.12B 165M 142M 130M 123M 227M 15.91B 231M 1.55B 602M 7.53B 620M 607M 26.23B | 1.24B 182M 156M 143M 136M 250M 17.53B 254M 1.71B 664M 8.3B 683M 669M 28.91B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-18 | 42.50 ¥ | -0.51% | 4,329,000 |
| 26-05-15 | 42.72 ¥ | -2.00% | 5,181,488 |
| 26-05-14 | 43.59 ¥ | -0.11% | 4,868,118 |
| 26-05-13 | 43.64 ¥ | +0.95% | 5,188,312 |
| 26-05-12 | 43.23 ¥ | +0.91% | 4,854,562 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
42.50
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
